Title: A phase 3 multicentre randomized double-blind placebo-controlled study evaluating the efficacy and safety of Ustekinumab in the treatment of adolescent subjects with moderate to severe plaque-type Psoriasis

Cardiff & Vale University Health Board

Principal Investigator

Project Details
Net value award figure for Cardiff University: £5,636.00
Start date: 01/01/2014
End date: 31/03/2014

Last updated on 2020-25-10 at 06:02